#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small intestine neuroendocrine tumour Netherton's syndrome Spinal cord injury Hypoparathyroidism Follicle centre lymphoma follicular grade I II – III refractory Paraganglion neoplasm Restless legs syndrome B-cell lymphoma recurrent Duchenne muscular dystrophy Systemic lupus erythematosus Acute respiratory distress syndrome Spina bifida Hypersensitivity pneumonitis Acute lymphocytic leukaemia recurrent Uveitis More trials…

    Learn about Rare Diseases

    Angiosarcoma – Life with Disease Leukoencephalopathy – Life with Disease Pelizaeus-Merzbacher disease – Treatment Hypereosinophilic syndrome – Diagnostics KBG syndrome – Life with Disease Burkitt’s lymphoma – Life with Disease Idiopathic pulmonary fibrosis Focal segmental glomerulosclerosis Breast angiosarcoma Hereditary motor and sensory neuropathy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ozanimod Hydrochloride Colistimethate Sodium LYSERGIDE TEDUGLUTIDE AZD3632 Brigatinib Wt1/Il15/Il15Ra Mrna Dc Ripretinib Zinc Sulphate Heptahydrate GSKVX000000017986 Ecoo2 Azithromycin TAGRAXOFUSP Vusolimogene Oderparepvec Noradrenaline Tartrate Stx-241 O15-Water Indocyanine Green Ceftazidime CILOSTAZOL More therapies…

    Learn about Your Condition

    Lichen planus Progressive supranuclear palsy Dementia Alzheimer's type Chorea Congenital pseudarthrosis Infertility male Death neonatal Neuroblastoma Pulmonary vascular disorder Cartilage injury Myasthenia gravis Restless legs syndrome Pseudomonas infection Sinusitis bacterial Autoimmune uveitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Multiprofile Hospital For Active Treatment…

University Multiprofile Hospital For Active Treatment Saint Georgi EAD

Bulevard Vasil Aprilov 15a, Plovdiv, 4002, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • Study of KarXT (trospium chloride and xanomeline tartrate) in patients with inadequately controlled schizophrenia symptoms

    Not recruiting

    3 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Bulgaria

  • Study on the Tolerability and Efficacy of Asciminib vs. Nilotinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myeloid Leukemia

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Nilotinib
    • Asciminib Hydrochloride
    Bulgaria Czechia France Germany Greece Hungary +4

  • Study on the Effectiveness and Safety of Gliclazide MR, Dapagliflozin, and Metformin for Patients with Type 2 Diabetes Not Well Controlled with Dapagliflozin

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Gliclazide
    • Metformin
    • Dapagliflozin
    Bulgaria Hungary Latvia Lithuania Poland

  • Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Charcoal, Activated
    • Colestyramine
    • Magnesium Citrate
    Bulgaria Croatia Czechia Estonia France Germany +9

  • Study on Inclisiran and Rosuvastatin for Lowering Cholesterol in Patients with High Cholesterol Levels

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hypercholesterolaemia
    Investigated Drugs:
    • Inclisiran
    • Rosuvastatin
    Bulgaria Czechia Estonia France Germany Latvia +2

  • Study on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Golcadomide
    • Apixaban
    • Betamethasone Sodium Phosphate
    Austria Bulgaria Czechia Denmark Finland France +11

  • Study Comparing Somapacitan and Somatropin for Growth in Children with Short Stature Due to Small for Gestational Age, Turner Syndrome, Noonan Syndrome, or Idiopathic Short Stature

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Noonan syndrome
    • Short stature
    • Small for dates baby
    Investigated Drugs:
    • Somapacitan
    • Somatropin
    Austria Belgium Bulgaria Croatia Finland France +10

  • Study Comparing Gadoquatrane with Gadoteric Acid, Gadobutrol, and Gadoteridol for MRI in Adults with Brain or Spinal Cord Issues

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Magnetic resonance imaging
    • Nervous system disorder
    Investigated Drugs:
    • Gadoquatrane
    • Gadobutrol
    • Gadoteric Acid
    Bulgaria Czechia France Germany Hungary Italy +1

  • Study on the Effectiveness and Safety of PLS240 for Treating Secondary Hyperparathyroidism in Patients with End-Stage Kidney Disease on Hemodialysis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hyperparathyroidism secondary
    Investigated Drugs:
    • Upacicalcet Sodium Hydrate
    Bulgaria Poland Portugal Spain

  • Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

    Not recruiting

    3 1
    Investigated Drugs:
    • Asundexian
    Austria Belgium Bulgaria Czechia Denmark Finland +14
Previous Page
1 … 15 16 17 18 19 20
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!